Interest Expense of Skye Bioscience, Inc. from 31 Jan 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Skye Bioscience, Inc. annual and quarterly Interest Expense in USD history and change rate from 31 Jan 2013 to 31 Dec 2025.
  • Skye Bioscience, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $436,936, a 2275% increase year-over-year.
  • Skye Bioscience, Inc. Interest Expense for the twelve months ending 31 Mar 2024 was $1,324,810, a 173% increase year-over-year.
  • Skye Bioscience, Inc. annual Interest Expense for 2025 was $0, a 100% decline from 2024.
  • Skye Bioscience, Inc. annual Interest Expense for 2024 was $749,308, a 17% decline from 2023.
  • Skye Bioscience, Inc. annual Interest Expense for 2023 was $906,270, a 36% increase from 2022.
Source SEC data
View on sec.gov
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)

Skye Bioscience, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 -$749,308 -100% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $749,308 -$156,962 -17% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $906,270 +$241,137 +36% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $665,133 -$104,026 -14% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024 2023 FY
2021 $769,159 +$62,774 +8.9% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $706,385 -$294,328 -29% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $1,000,713 +$905,950 +956% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
2018 $94,763 +$94,096 +14107% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020 2019 FY
2017 $667 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY
2013 $2,151 01 Nov 2012 31 Oct 2013 10-K 27 Jan 2014 2013 FY

Skye Bioscience, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,324,810 $436,936 +$418,540 +2275% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $906,270 $430,138 +$380,567 +768% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $525,703 $271,307 +$60,078 +28% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $465,625 $186,429 -$18,871 -9.2% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $484,496 $18,396 -$180,637 -91% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $665,133 $49,571 -$149,267 -75% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 $814,400 $211,229 +$15,871 +8.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $798,529 $205,300 +$15,242 +8% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $783,287 $199,033 +$14,128 +7.6% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $769,159 $198,838 +$13,047 +7% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $756,112 $195,358 +$12,744 +7% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $743,368 $190,058 +$18,433 +11% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $724,935 $184,905 +$18,550 +11% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $706,385 $185,791 -$103,347 -36% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $809,732 $182,614 -$118,933 -39% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $928,665 $171,625 -$122,340 -42% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $1,051,005 $166,355 +$50,292 +43% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $1,000,713 $289,138 +$232,083 +407% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $768,630 $301,547 +$301,547 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $467,083 $293,965 +$293,965 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $173,118 $116,063 +$78,355 +208% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $94,763 $57,055 01 Oct 2018 31 Dec 2018 10-K 23 Mar 2020 2019 FY
Q3 2018 $0 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $0 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $37,708 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q2 2014 $210,667 $776 +$114 +17% 01 May 2014 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 $210,781 $307* -$342 31 Jan 2014 30 Apr 2014 10-Q 05 Jun 2014 2014 Q2
Q4 2013 $210,439 $410 -$212,590 -100% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $2,151 $212,160 01 Aug 2013 31 Oct 2013 10-K 27 Jan 2014 2013 FY
Q2 2013 $662 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2014 Q3
Q1 2013 $649 31 Jan 2013 30 Apr 2013 10-Q 05 Jun 2014 2014 Q2
Q4 2012 $213,000 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.